Related Experiment Video

Updated: Aug 15, 2026

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method
08:15

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method

Published on: May 22, 2019

Hypertension and the kidney

Michael Wiederkehr1, Robert Toto, Andrew Z Fenves

  • 1Dallas Nephrology Associates, Dallas, Texas 75204-6225, USA. wiederkehrm@dneph.com

Seminars in Nephrology
|October 6, 2005
PubMed

Insights

Hypertension and diabetes are major causes of chronic kidney disease (CKD). Aggressively managing blood pressure and blood sugar is crucial for preventing kidney disease progression and its severe outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Hypertension is a primary risk factor for chronic kidney disease (CKD), potentially leading to end-stage renal disease.
  • Diabetes mellitus is the leading cause of end-stage renal disease in Western countries.
  • Both hypertension and diabetes contribute significantly to CKD development and its complications.

Purpose of the Study:

  • To review the pathophysiologic mechanisms linking hypertension and kidney disease.
  • To discuss therapeutic strategies for managing hypertension in the context of renal insufficiency.
  • To highlight the importance of early microalbuminuria detection and management.

Main Methods:

  • Review of existing literature on hypertension, diabetes, and chronic kidney disease.
  • Analysis of pathophysiologic pathways involved in renal damage.
  • Evaluation of therapeutic interventions, including renin-angiotensin system blockade.

Main Results:

  • Effective hypertension control is a proven method for preventing renal disease.
  • Reducing systemic and intraglomerular pressure is key in managing renal insufficiency.
  • Renin-angiotensin system inhibitors offer specific renal and cardiovascular benefits.

Conclusions:

  • Aggressive control of hypertension and diabetes is essential for reducing CKD risk.
  • Targeted therapies, such as renin-angiotensin system blockers, are vital for kidney protection.
  • Early detection and treatment of microalbuminuria are integral to managing hypertensive kidney disease.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...